đŹ Current Disease Focus:
Task Progress: 0%
đĽ Active Problem Solvers
0
đ Experts collaborating globally
⥠Current Task Assignment
𧏠Genetic Analysis
đ Matching experts to specific tasks
đ Resource Allocation by Research Phase:
đ Data Analysis
𧪠Experimental Design
đŹ Clinical Trials
đ Treatment Development
This study will assess the immunogenicity and safety of GlaxoSmithKline (GS...
Status
Completed
Location
Multiple Locations
Start Date
1999-01
Trial ID
NCT01457508
Treatments Being Tested
Pediacel⢠is currently licensed in the UK for use as a 3 dose regimen for t...
Status
Completed
Location
Multiple Locations
Start Date
2006-02
Trial ID
NCT00287092
Treatments Being Tested
This protocol posting deals with objectives \& outcome measures of the exte...
Status
Completed
Location
GSK Investigational Site
Start Date
2006-05
Trial ID
NCT00322335
The purpose of this Phase IIIb study is to evaluate the immunogenicity, rea...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-12-01
Trial ID
NCT00586612
Treatments Being Tested
The new formulation administered as a 4th consecutive dose will be compared...
Status
Completed
Location
GSK Investigational Site
Start Date
2008-02-14
Trial ID
NCT00611559
Treatments Being Tested
The purpose of this study is to assess the safety in terms of fever (rectal...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-04-25
Trial ID
NCT00463437
The purpose of this primary vaccination phase is to demonstrate the non-inf...
Status
Completed
Location
GSK Investigational Site
Start Date
2006-04
Trial ID
NCT00327184